- Pharmacological ascorbate induces 'BRCAness' and enhances the effects of Poly(ADP-Ribose) polymerase inhibitors against BRCA1/2 wild-type ovarian cancer.
- Ma Y, Chen P, Drisko JA, Khabele D, Godwin AK, Chen Q.
- Oncol Lett. 2020 Apr;19(4):2629-2638. doi: 10.3892/ol.2020.11364. Epub 2020 Jan 31.
- PMID: 32218813
- PubMed abstract
- Source abstract